TECHNOLOGY & INDICATIONS OVERVIEW

Aptose Biosciences is focused on small molecule oncology therapeutics, with first-in-class or best-in-class agents in or nearing clinical development.  The company’s goal is to identify niche oncology indications from which genetic or gene expression signatures and validated diagnostic biomarkers may be used to identify the optimal patient population.